Clinical Trials Logo

Filter by:
NCT ID: NCT04161807 Completed - Chronic Migraine Clinical Trials

Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine

Start date: September 18, 2019
Phase: N/A
Study type: Interventional

This study is intended to evaluate the efficacy and safety of Nerivio, an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine, for the acute treatment of migraine in people with chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The study duration consists of a 4 weeks of active treatment with the device in about 40 patients.

NCT ID: NCT04154189 Completed - Osteosarcoma Clinical Trials

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Start date: March 23, 2020
Phase: Phase 2
Study type: Interventional

This Is a Multicenter, Randomized, Open-Label, Parallel-Group, Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents, and Young Adults with Relapsed or Refractory Osteosarcoma.

NCT ID: NCT04153916 Completed - Bell Palsy Clinical Trials

Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve

Bioniceye
Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Artificial eye blinking stimulation following damage to the facial nerve. Group 1 - Patients with a persistent unilateral facial paralysis (palsy) that underwent an operation for facial reanimation Group 2 - Patients with temporary unilateral facial paralysis, secondary to unilateral Bell's palsy. Primary objective: To evaluate whether the Neurotigger device can elicit a complete or a partial eyelid closure of the affected eye. Secondary objective: To optimize the location of the Neurotrigger's electrodes, and define the level of the pain generated, if any, during device implementation and stimulation, as well as the method for the personal adjustment of the precise pattern of stimulation (strength, intensity, other features) to achieve eye blinking for different patients.

NCT ID: NCT04146337 Completed - Clinical trials for Carbapenem-Resistant Enterobacteriaceae Infection

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

Start date: October 12, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

2:1, open-label, single center, randomized controlled trial comparing FMT vs. no intervention for CRE carriers,

NCT ID: NCT04145544 Completed - Clinical trials for Cerebrospinal Fluid Leak

A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.

NEOART
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of ArtiFascia® in comparison with commercially available dural substitutes in patients requiring Dural repair following neurosurgery. Patients with planned cranial neurosurgery can take part in this study. During the surgery the soft membrane that covers the brain (called dura) is likely to be cut and damaged. A damaged dura can cause a leakage of brain fluids (cerebrospinal fluid [CSF] leakage) and increase the risk of infections. Sponsor of this study has developed the ArtiFascia®. ArtiFascia® is a medical synthetic dural substitute that is absorbed by the body. ArtiFascia® supports the re-formation of a new dura. In addition it has a sealant layer that can reduce CSF leakage and infection.

NCT ID: NCT04145310 Completed - Low Back Pain Clinical Trials

BOL-DP-o-04 in Patients With Low Back Pain and Sciatica

Start date: November 27, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The study is aimed to evaluate the pain-relieving effect of BOL-DP-o-04, in addition to SOC, on Low Back Pain and Sciatica.

NCT ID: NCT04143867 Completed - Clinical trials for Stress Urinary Incontinence

The Nolix Feasibility Efficacy and Safety Study

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study is an open label, prospective, feasibility study with the Nolix device used for temporary treatment of Stress Urinary Incontinence (SUI) in subjects, serving as their own controls.

NCT ID: NCT04138732 Completed - Health Behavior Clinical Trials

Health Behaviors of Medical Personnel in Hospital Maternity Ward

Start date: June 15, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to characterize the existing health behaviors and obstacles to healthy lifestyle among the medical staff in a maternity ward in order to develop a specifically-tailored intervention to help improve the health behaviors of hospital shift workers.The findings will be used to establish a community-based participatory health-promoting program in the ward, engaging the staff in its development and implementation.

NCT ID: NCT04135612 Completed - Clinical trials for Post Partum Depression

The Impact of a Daily Smartphone-based Communication Among Postpartum Women on Breastfeeding Rates

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

We will aim to study the impact of introducing a smartphone-based daily feedback and communication platform between postpartum women delivering at our institute and a multidisciplinary breastfeeding-support team (obstetricians, neonatologists, midwives, lactation consultants, nurses, and psychologist) on breastfeeding rates.

NCT ID: NCT04132453 Completed - Clinical trials for Blood Pressure Measurement

Continuous Blood Pressure and Waveform Measurements Comparison Between Invasive Arterial Line and PPG Sensor

Start date: June 19, 2018
Phase:
Study type: Observational

The purpose of this study is to compare blood pressure values (systolic, diastolic, mean arterial pressure) and waveform as recorded by a radial arterial line catheter to the waveform and values as calculated by the Sensifree's algorithm from a PPG sensor from a variety group of patients during elective surgeries.